These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 26243853)

  • 41. Catatonia.
    Walther S; Strik W
    CNS Spectr; 2016 Aug; 21(4):341-8. PubMed ID: 27255726
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Catatonia in a University Inpatient Service (1985-1990).
    Pataki J; Zervas IM; Jandorf L
    Convuls Ther; 1992; 8(3):163-173. PubMed ID: 11941166
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A comparative study of "Idiopathic catatonia" with catatonia in schizophrenia.
    Krishna KR; Maniar RC; Harbishettar VS
    Asian J Psychiatr; 2011 Jun; 4(2):129-33. PubMed ID: 23051079
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Phenomenology and Treatment Response in Catatonia: A Hospital Based Descriptive Study.
    Swain SP; Behura SS; Dash MK
    Indian J Psychol Med; 2017; 39(3):323-329. PubMed ID: 28615768
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The study of pediatric catatonia supports a home of its own for catatonia in DSM-5.
    Dhossche D; Cohen D; Ghaziuddin N; Wilson C; Wachtel LE
    Med Hypotheses; 2010 Dec; 75(6):558-60. PubMed ID: 20702047
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Has Kahlbaum syndrome disappeared or is it underdiagnosed? Reexamining the nosology of catatonia.
    Rao NP; Kasal V; Mutalik NR; Behere RV; Venkatasubramanian G; Varambally S; Gangadhar BN
    J ECT; 2012 Mar; 28(1):62-3. PubMed ID: 22343585
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuroleptic malignant syndrome following catatonia: Vigilance is the price of antipsychotic prescription.
    Reilly TJ; Cross S; Taylor DM; Haslam R; Tomlin SC; Gaastra B
    SAGE Open Med Case Rep; 2017; 5():2050313X17695999. PubMed ID: 28491312
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Are catatonia and neuroleptic malignant syndrome related conditions?].
    Vesperini S; Papetti F; Pringuey D
    Encephale; 2010 Apr; 36(2):105-10. PubMed ID: 20434626
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuroleptic malignant syndrome or catatonia? Trying to solve the catatonic dilemma.
    Lang FU; Lang S; Becker T; Jäger M
    Psychopharmacology (Berl); 2015 Jan; 232(1):1-5. PubMed ID: 25407348
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Differential diagnosis of acute life threatening catatonia and malignant neuroleptic syndrome--a case report].
    Hermle L; Oepen G
    Fortschr Neurol Psychiatr; 1986 Jun; 54(6):189-95. PubMed ID: 2873091
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Catatonia Secondary to Sudden Clozapine Withdrawal: A Case with Three Repeated Episodes and a Literature Review.
    Bilbily J; McCollum B; de Leon J
    Case Rep Psychiatry; 2017; 2017():2402731. PubMed ID: 28396815
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic heterogeneity in catatonic schizophrenia: a family study.
    Beckmann H; Franzek E; Stöber G
    Am J Med Genet; 1996 May; 67(3):289-300. PubMed ID: 8725746
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The use of atypical antipsychotics in the treatment of catatonia.
    Van Den Eede F; Van Hecke J; Van Dalfsen A; Van den Bossche B; Cosyns P; Sabbe BG
    Eur Psychiatry; 2005 Aug; 20(5-6):422-9. PubMed ID: 15964746
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Catatonia and neuroleptic malignant syndrome: two disorders on a same spectrum? Three case reports].
    Luchini F; Lattanzi L; Bartolommei N; Cosentino L; Casamassima F; Litta A; Mauri M; Cassano GB
    Riv Psichiatr; 2012; 47(2):178-85. PubMed ID: 22622253
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Distribution and frequency of clinical criteria and rating scales for diagnosis and assessment of catatonia in different study types.
    Hirjak D; Brandt GA; Fritze S; Kubera KM; Northoff G; Wolf RC
    Schizophr Res; 2024 Jan; 263():93-98. PubMed ID: 36610862
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Catatonia and neuroleptic malignant syndrome: two disorders on a same spectrum? Four case reports.
    Luchini F; Lattanzi L; Bartolommei N; Cosentino L; Litta A; Kansky C; Mauri M; Cassano GB; Fagiolini A; Casamassima F
    J Nerv Ment Dis; 2013 Jan; 201(1):36-42. PubMed ID: 23274293
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular hypotheses to explain the shared pathways and underlying pathobiological causes in catatonia and in catatonic presentations in neuropsychiatric disorders.
    Peter-Ross EM
    Med Hypotheses; 2018 Apr; 113():54-64. PubMed ID: 29523295
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Catatonia: a syndrome appears, disappears, and is rediscovered.
    Fink M
    Can J Psychiatry; 2009 Jul; 54(7):437-45. PubMed ID: 19660165
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Catatonia in childhood and adolescence.
    Takaoka K; Takata T
    Psychiatry Clin Neurosci; 2003 Apr; 57(2):129-37. PubMed ID: 12667158
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Catatonia and neuroleptic malignant syndrome in view of a psychopathological and pathophysiological overlap: a brief review].
    Asztalos Z; Egervári L; Andrássy G; Faludi G; Frecska E
    Neuropsychopharmacol Hung; 2014 Mar; 16(1):19-28. PubMed ID: 24687015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.